Niagen Bioscience Launches NAD Pharmaceuticals, Its Wholly Owned Subsidiary Focused On Developing Therapies For Accelerated Aging And Rare Genetic Diseases

뉴스 본문을 불러오고 있어요.

Niagen Bioscience Launches NAD Pharmaceuticals, Its Wholly Owned Subsidiary Focused On Developing Therapies For Accelerated Aging And Rare Genetic Diseases | 웨이프 WAPE

Niagen Bioscience Launches NAD Pharmaceuticals, Its Wholly Owned Subsidiary Focused On Developing Therapies For Accelerated Aging And Rare Genetic Diseases

기사 요약

관련 종목

댓글 —